NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-295-2004-0-IE-12 Attenuated Human Parainfluenza Virus, Methods And Uses Thereof IE EP 06850427.3 Issued
NIAID E-295-2004-0-DE-09 Attenuated Human Parainfluenza Virus, Methods And Uses Thereof DE EP 06850427.3 Issued
NIAID E-295-2004-0-FR-10 Attenuated Human Parainfluenza Virus, Methods And Uses Thereof FR EP 06850427.3 Issued
NIAID E-295-2004-0-CH-08 Attenuated Human Parainfluenza Virus, Methods And Uses Thereof CH EP 06850427.3 Issued
NIAID E-295-2004-0-GB-11 Attenuated Human Parainfluenza Virus, Methods And Uses Thereof GB EP 06850427.3 Issued
NIAID E-295-2004-0-US-07 Attenuated Human Parainfluenza Virus, Methods, And Uses Thereof US National Stage 13/501,447 9034343 Issued PDF
NIAID E-295-2004-0-PCT-02 Attenuated Human Parainfluenza Virus, Methods And Uses Thereof PCT PCT COMB PCT/US2006/000666 Expired
NCI E-321-2000-0-US-03 Antisense Oligonucleotides Targeting Folate Receptor Alpha, And the Use Thereof US DIV 11/328,449 Abandoned
NIAID E-295-2004-0-CA-04 Attenuated Human Parainfluenza Virus, Methods And Uses Thereof CA National Stage 2605878 Abandoned
NIAID E-295-2004-0-AU-03 Attenuated Human Parainfluenza Virus, Methods And Uses Thereof AU National Stage 2006332044 Abandoned
NIAID E-295-2004-0-JP-06 Attenuated Human Parainfluenza Virus, Methods And Uses Thereof JP National Stage 2008-511104 Abandoned
NHLBI E-254-2003-2-US-02 Use of Nitrite Salts For the Treatments of Cardiovascular Conditions US National Stage 10/563,682 Abandoned
NIAMS E-355-2004-0-PCT-02 AGONISTS AND ANTAGONISTS OF TNFRII/CD120B FOR TREATMENT OF IMMUNE-RELATED DISEASES PCT PCT PCT/US2006/000465 Abandoned
NCI E-207-2005-1-US-01 HPLC/MS And SFC/MS Analysis Of Estrogens And Their Metabolites From Human Serum US 60/756,867 Abandoned
NCI E-066-1998-0-US-11 Anthrax Lethal Factor is A MAPK Kinase Protease US DIV 11/326,985 7183071 Abandoned PDF
NCI E-181-2006-0-US-01 Unique MicroRNA Molecular Profiles In Lung Cancer Diagnosis And Prognosis US 60/756,400 Abandoned
NIAID E-115-2000-0-US-16 Attenuated Human-Bovine Chimeric Parainfluenza Virus (PIV) Vaccines US CON 11/324,284 7632508 Expired PDF
NINDS E-181-2002-0-US-03 METHODS AND DEVICES FOR INTRAMUSCULAR STIMULATION OF UPPER AIRWAY AND SWALLOWING MUSCLE GROUPS US ORD 10/529,401 7606623 Abandoned PDF
NCI E-339-2004-0-AU-05 FRAMEWORK RESIDUE SUBSTITUTED HUMANIZED COL-1 ANTIBODIES AND THEIR USE AU National Stage 2005322869 Abandoned
NCI E-339-2004-0-EP-06 Framework Residue Substituted Humanized Col-1 Antibodies and their Use EP National Stage 05855920.4 Abandoned
NCI E-339-2004-0-PCT-02 A Variant Of Humanized Col-1 Antibody Rendered Less Immunogenic By Replacing, With Their Human Counterparts, Most Of The Murine Framework Residues That Were Presumed Crucial For Antigen Binding PCT PCT PCT/US2005/047431 Expired
NCI E-256-1998-1-US-01 Carcinoembryonic Antigen (CEA) Peptides US CIP 11/321,868 Abandoned
NCI E-339-2004-0-CA-04 FRAMEWORK RESIDUE SUBSTITUTED HUMANIZED COL-1 ANTIBODIES AND THEIR USE CA National Stage 2593693 Abandoned
NIAID E-142-1996-3-KR-12 "Production of Attenuated Respiratory Syncytial Virus Vaccines from Cloned Nucleotide Sequences" KR DIV 10-2005-7024993 Abandoned
NCI E-137-2002-0-HK-09 METHOD FOR TREATING CANCER IN HUMANS HK National Stage 05111980.4 Abandoned
NIAID E-243-2006-1-US-01 Nitroimidadzole Analogs With Improved TB Activity US 60/753,781 Abandoned
NIAID E-243-2006-0-US-01 Nitroimidadzole Analogs With Improved TB Activity US 60/753,763 Abandoned
NIAID E-055-1999-0-US-03 Identification and use of High Efficacy Vaccine Antigens Which Modulate Antigen Presenting Cells US CON 11/315,081 Abandoned
NIAID E-145-2004-0-US-01 Chimpaneze Monoclonal Antibodies That Neutralizes Vaccinia Virus (and Possibly Othe Pox Viruses) US 60/753,437 Abandoned
NIAID E-046-2005-0-PCT-02 A Potent IL-12 Inducing Protein From Toxoplasma Gondii With MyD88-Mediated Adjuvant-like Function PCT PCT PCT/US2005/046783 Abandoned
NIAID E-146-2004-0-PCT-02 Monoclonal Antibodies That Neutralizes Anthrax Protective Antigen (PA) Toxin PCT PCT PCT/US2005/046790 Expired
NIDDK E-002-2006-0-US-01 Methods for Producing and Using Pancreatic Endocrine Cells US 60/752,822 Abandoned
NCI E-103-2005-2-US-01 Papillomavirus L2 N-terminal Peptides For The Induction Of Broadly Cross-neutralizing Antibodies US 60/752,268 Abandoned
NIAMS E-011-2005-0-US-12 Cross-linked Polymer Matrices, And Methods Of Making And Using Same US DIV 11/314,659 Abandoned
NIDCD E-222-2003-1-US-02 Variants of Human Taste Receptor Genes US ORD 10/561,487 7579453 Issued PDF
NCI E-335-2005-0-US-01 Targeted Detection, Fluorescence Imaging, And Photo-Dynamic Therapy Of Disseminated Intraperitoneal Cancer Metastases US 60/751,429 Abandoned
NCI E-057-2006-0-US-01 Autoantibody Screening For Cancer Diagnosis US 60/751,133 Abandoned
NIAID E-241-2001-1-AU-03 Development of a Preventive Vaccine for Filovirus Infection in Primates AU DIV 2005244541 Expired
NCI E-212-2004-1-PCT-01 Cancer-Specific SPANX-N Markers PCT PCT COMB PCT/US2005/045317 Abandoned
NCI E-212-2004-1-EP-04 Cancer-Specific SPANX-N Markers EP National Stage 05854102.0 Abandoned
NICHD E-353-2003-0-HK-33 Methods Of Treating And/or Preventing Autoimmune Diseases HK National Stage 051110037 Abandoned
NCI E-212-2004-1-CA-03 Cancer-Specific SPANX-N Markers CA National Stage 2591918 Abandoned
NCI E-212-2004-1-AU-02 Cancer-Specific SPANX-N Markers AU National Stage 2005316532 Abandoned
NCI E-182-2005-0-US-01 Anti-Viral Arylstibonic Acid Compounds US 60/751,126 Abandoned
NCI E-121-2005-0-US-03 Polymer-linked Pseudomonas Exotoxin Immunotoxin US ORD 11/793,165 Abandoned
NIA E-146-1993-0-US-48 METHOD OF TREATING ATHEROSCLEROSIS OR RESTENOSIS USING MICROTUBULE STABILIZING AGENT US CON 11/304,362 Abandoned
NCI E-121-2005-0-EP-04 Polymer-linked Pseudomonas Exotoxin Immunotoxin EP National Stage 05857077.1 Abandoned
NCI E-121-2005-0-PCT-02 Polymer-linked Pseudomonas Exotoxin Immunotoxin PCT PCT PCT/US05/045177 Expired
NCI E-325-2005-0-US-01 Expansion of Natural Killer and CD8 T-cells With IL-15R/ligand Activator Complexes US 60/750,639 Abandoned
NIAID E-083-2005-0-US-03 Negative Strand RNA Virus Replicon US National Stage 10/560,655 7585667 Abandoned PDF